The biggest surprise was diabetes itself. If metformin were going to win anywhere, surely it'd be here. Yet 60% of the lifestyle group developed type 2 diabetes over follow-up, vs 69% on placebo and 71% on metformin. The diabetes drug had the most diabetes.
